Same mutations detected by the multicancer early detection test at index time point could be ID'd at 8.6- to 79-fold lower mutant allele fractions.

Analysis of symptoms experienced by adolescents with cancer receiving chemotherapy were identified by prevalence, severity, and distress, and categorized into specific symptom clusters. Researchers ...

(HealthDay News) — Medicare beneficiaries with preexisting atrial fibrillation undergoing coronary artery bypass grafting (CABG) who undergo concomitant surgical ablation have a survival advantage, ...

(HealthDay News) — Mindfulness (MI) and transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex offer therapeutic benefit for reducing situational urgency urinary ...

Investigators evaluated the efficacy and safety of different doses of MK-2060, a monoclonal antibody against Factor XI, to prevent vascular access clotting in patients receiving hemodialysis via an ...

Increased mortality seen in association with longer nap duration, greater intraindividual variability, more naps from 11 a.m. to 1 p.m., 1 to 3 p.m.

(HealthDay News) — A healthy diet improves cardiometabolic risk factors, even if not associated with weight loss (WL), according to a study published online June 5 in the European Journal of ...

(HealthDay News) — For critically ill adults with sepsis, statin use is associated with reduced mortality, according to a study published online June 5 in Frontiers in Immunology.

The FDA has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.

SGLT2 inhibitors have been shown to reduce risk of acute kidney injury, but whether kidney effects are modified by risk of acute dips in eGFR is unknown.

Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.

The U.S. Centers for Disease Control and Prevention (CDC) updated its guidance last week to recommend measles-mumps-rubella ...